RECRUITING

Brain Mechanisms of Reducing Polysubstance Use

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The proposed study will test whether neurofeedback (NF) could optimize integrative body-mind training (IBMT) practice.

Official Title

Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention 2

Quick Facts

Study Start:2023-09-01

Study Completion:2026-08-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06324786

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* At least 18 years old * Free of any psychiatric diagnoses or medication (besides a substance use disorder (SUD) to alcohol, tobacco, or cannabis) * In the past month, at least 4 episodes of heavy episodic drinking; at least 3 occasions of cannabis use; and daily cigarette use for at least the past month * Normal or corrected-to-normal vision * Written informed consent * No previous meditation or NF experiences	* Any psychiatric diagnoses other than an SUD * Medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females) * Excluding cannabis, evidence of recent (past month) illicit drug use

Inclusion Criteria

Exclusion Criteria

* At least 18 years old
* Free of any psychiatric diagnoses or medication (besides a substance use disorder (SUD) to alcohol, tobacco, or cannabis)
* In the past month, at least 4 episodes of heavy episodic drinking; at least 3 occasions of cannabis use; and daily cigarette use for at least the past month
* Normal or corrected-to-normal vision
* Written informed consent
* No previous meditation or NF experiences

* Any psychiatric diagnoses other than an SUD
* Medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females)
* Excluding cannabis, evidence of recent (past month) illicit drug use

Contacts and Locations

Study Contact

YiYuan Tang

CONTACT

4807903577

yiyuan@asu.edu

Study Locations (Sites)

YiYuan Tang

Phoenix, Arizona, 85004

United States

Collaborators and Investigators

Sponsor: Arizona State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-01

Study Completion Date2026-08-31

Study Record Updates

Study Start Date2023-09-01

Study Completion Date2026-08-31

Terms related to this study

Additional Relevant MeSH Terms

Multiple Drug Use